Search results
Cellectar Biosciences stock target raised, maintains outperform on Q1 results By Investing.com
Investing.com· 2 days agoOn Tuesday, Oppenheimer showed confidence in Cellectar Biosciences shares (NASDAQ:CLRB) by raising...
Those sickened by U.S. nuclear testing program take their fight to Congress
NPR· 5 hours agoIn all, the Justice Department program has disbursed $2.7 billion in payments to more 40,000...
Q1 2024 Monday.Com Ltd Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 17 hours agoHynes; Analyst; Canaccord Genuity Corp., Research Division George Michael Iwanyc; Associate; Oppenheimer & Co. Inc., Research Division Jackson Edmund Ader; MD of Software ...
Acrivon Therapeutics maintains Outperform rating, $21 target By Investing.com
Investing.com· 2 days agoOn Tuesday, Oppenheimer maintained its positive stance on Acrivon Therapeutics Inc (NASDAQ: ACRV),...
YouTube prankster sneaks onto Manchester United bus
The Independent via Yahoo Sports· 3 days agoThe YouTube prankster who gatecrashed Oppenheimer’s Bafta acceptance speech, has recently evaded security again, and found his way onto the Manchester...
Regal Rexnord (NYSE:RRX) Upgraded by StockNews.com to Buy
ETF DAILY NEWS· 17 hours agoStockNews.com upgraded shares of Regal Rexnord (NYSE:RRX – Free Report) from a hold rating to a buy rating in a research report report published on Monday morning. Other research analysts have ...
Insider Selling: CEO Matthew Oppenheimer Sells 20,832 Shares of
Guru Focus· 3 days agoOn May 14, 2024, Matthew Oppenheimer, the Chief Executive Officer of Remitly Global Inc (RELY, Financial), executed a sale of 20,832 shares of the company. Following this ...
Wall Street’s biggest bull wishes he'd been a bigger bull
Yahoo Finance via AOL· 10 hours agoBelksi’s call proved to be prescient. And before the calendar flipped, Goldman Sachs, Deutsche Bank,...
1 Wall Street Analyst Thinks This Stock-Split Stock Is Going to $67. Is It a Buy Around $60?
Motley Fool via Yahoo Finance· 1 day agoCould he be right? Always a tough competitor Several days before Walmart was slated to unveil its...
KKR Stock Sees Surge of Approximately 8.03% in Last Five Days – Knox Daily
Knox Daily· 13 hours agoInc [KKR] has been an Outperform and the price target has been revised to $96. Analysts at Oppenheimer resumed the stock at ‘”an Outperform”‘ outlook in a report released ...
